Pharmacokinetics and blood levels of polychlorinated biphenyls

Toxicological Reviews

Volumn 22, Issue 4, 2003, Pages 203-215

  Lotti, Marcelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROCLOR 1242; AROCLOR 1254; AROCLOR 1260; DIBENZOFURAN DERIVATIVE; DIOXIN; POLYCHLORINATED BIPHENYL DERIVATIVE; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; TETRACHLOROBIPHENYL;

BLOOD ANALYSIS; BLOOD TOXICITY; BREAST CANCER; CANCER RISK; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; EYE TOXICITY; HALF LIFE TIME; HEMOCONCENTRATION; HUMAN; ISOMER; LIPOPHILICITY; LIVER TOXICITY; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL TOXICOLOGY; PLASMA HALF LIFE; REVIEW; RISK ASSESSMENT; SKIN TOXICITY; TOXICOKINETICS;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; POLYCHLORINATED BIPHENYLS;

EID: 3242879950     PISSN: 11762551     EISSN: None     Source Type: Journal    
DOI: 10.2165/00139709-200322040-00003     Document Type: Review

References (163)

1. World Health Organization. International programme on chemical safety: polychlorinated biphenyls and terphenyls. 2nd ed. Environmental Health Criteria 140. Geneva: World Health Organization, 1993
2. Djien Liem AK, Fürst P, Rappe C. Exposure of populations to dioxins and related compounds. Food Addit Contam 2000; 17: 241-59
3. Damstra T, Barlow S, Bergman A, et al., editors. Global assessment of the state-of-the-science of endocrine disruptors. International Programme on Chemical Safety. Geneva: World Health Organization, 2002
4. Safe SH. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 1994; 24: 87-149
5. Giesy JP, Kannan K. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment. Crit Rev Toxicol 1998; 28: 511-69
6. Stellmarr SD, Djordjevic MV, Muscat JE, et al. Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev 1998; 7: 489-96
7. Wolff MS, Camann D, Gammon M, et al. Proposed PCB congener groupings for epidemiological studies. Environ Health Perspect 1997; 105: 13-4
8. De Voto E, Fiore BJ, Millikan R, et al. Correlations among human blood levels of specific PCB congeners and implications for epidemiologic studies. Am J Ind Med 1997; 32: 606-13
9. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol 1990; 21: 51-88
10. Safe S. Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. Teratog Carcinog Mutagen 1998; 17: 285-304
11. Wilkinson GR. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: Hardman JG, Limbird LE, editors. Goodman & Gilmann's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001: 3-29
12. Nakanishi Y, Shigematsu N, Kurita Y, et al. Respiratory involvement and immune status in Yusho patients. Environ Health Perspect 1985; 59: 31-6
13. Urabe H, Asahi M. Past and current dermatological status of Yusho patients. Environ Health Perspect 1985; 59: 11-5
14. Lü YC, Wu YC. Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ Health Perspect 1985; 59: 17-29
15. Hsu ST, Ma CI, Hsu SKH, et al. Discovery and epidemiology of PCB poisoning in Taiwan: a four-year followup. Environ Health Perspect 1985; 59: 5-10
16. Kimbrough RD, Doemland ML, Le Vois ME. Mortality in male and female capacitor workers exposed to polychlorinated biphenyls. J Occup Environ Med 1999; 41: 161-71
17. Negri E, Bosetti C, Fattore E, et al. Environmental exposure to polychlorinated biphenyls (PCB) and breast cancer: a systematic review of the epidemiological evidence. Eur J Cancer Prev 2003; 12: 509-16
18. Van den Berg M, Birnbaum L, Bosveld ATC, et al. Toxic Equivalency Factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998; 106: 775-92
19. Van Birgelen APJM, van den Berg M. Toxicokinetics. Food Addit Contam 2000; 17: 267-73
20. Yakushiji T, Watanabe I, Kuwabara K, et al. Rate of decrease and half-life of polychlorinated biphenyls (PCBs) in the blood of mothers and their children occupationally exposed to PCBs. Arch Environ Contam Toxicol 1984; 13: 341-5
21. Longnecker MP, Klebanoff MA, Gladen BC, et al. Serial levels of serum organochlorines during pregnancy and postpartum. Arch Environ Health 1999; 54: 110-4
22. Covaci A, Jorens PH, Jacquemyn Y, et al. Distribution of PCBs and organochlorine pesticides in umbilical cord and maternal serum. Sci Total Environ 2002; 298: 45-53
23. Matthews HB, Dedrick RL. Parmacokinetics of PCBs. Ann Rev Pharmacol Toxicol 1984; 24: 85-103
24. Schlummer M, Moser GA, McLachlan MS. Digestive tract absorption of PCDD/Fs, PCBs and HCB in humans: mass balances and mechanistic considerations. Toxicol Appl Pharmacol 1998; 152: 128-37
25. Moser GA, McLachlan MS. The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract. Chemosphere 2001; 45: 201-11
26. Moser GA, McLachlan MS. Modeling digestive tract absorption and desorption of lipophilic organic contaminants in humans. Environ Sci Technol 2002; 36: 3318-25
27. Maroni M, Colombi A, Cantoni S, et al. Occupational exposure to polychlorinated biphenyls in electrical workers: I. environmental and blood polychlorinated biphenyls concentrations. Br J Ind Med 1981; 38: 49-54
28. Wolff MS, Fischbein A, Thornton J, et al. Body burden of polychlorinated biphenyls among persons employed in capacitor manufacturing. Int Arch Occup Environ Health 1982; 49: 199-208
29. Smith AB, Schloemer J, Lowry LK, et al. Metabolic and health consequences of occupational exposure to polychlorinated biphenyls. Br J Ind Med 1982; 39: 361-9
30. Wolff MS. Occupational exposure to polychlorinated biphenyls (PCBs). Environ Health Perspect 1985; 60: 133-8
31. Lees PSJ, Corn M, Breysse PN. Evidence for dermal absorption as the major route of body entry during exposure of transformer maintenance and repairmen to PCBs. Am Ind Hyg Assoc J 1987; 48: 257-64
32. Qiao GL, Riviere JE. Enhanced systemic tissue distribution after dermal versus intravenous 3,3′,4,4′- tetrachlorobiphenyl exposure: limited utility of radiolabel blood area under the curve and excretion data in dermal absorption calculations and tissue exposure assessment. Toxicol Appl Pharmacol 2001; 177: 26-37
33. Chia LG, Chu FL. Neurological studies on polychlorinated biphenyl (PCB)-poisoned patients. Am J Ind Med 1984; 5: 117-26
34. Chen PH, Wong CK, Rappe C, et al. Polychlorinated biphenyls, dibenzofurans and quaterphenyls in toxic rice-bran oil and in the blood and tissues of patients with PCB poisoning (Yu-Cheng) in Taiwan. Environ Health Perspect 1985; 59: 59-65
35. Parham FM, Kohn MC, Matthews HB, et al. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. Toxicol Appl Pharmacol 1997; 144: 340-7
36. De Vito MJ, Ross DG, Dupuy AE, et al. Dose-response relationships for disposition and hepatic sequestration of polyhalogenated dibenzo-p-dioxins, dibenzofurans, and biphenyls following subchronic treatment in mice. Toxicol Sci 1998; 46: 223-34
37. Masuda Y, Kuroki H, Haraguchi K, et al. PCB and PCDF congeners in the blood and tissues of Yusho and Yu-Cheng patients. Environ Health Perspect 1985; 59: 53-8
38. Carrier G, Brunet RC, Brodeur J. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. Toxicol Appl Pharmacol 1995; 131: 253-66
39. Kunita N, Kashimoto T, Miyata H, et al. Causal agents of Yusho. Am J Ind Med 1984; 5: 45-58
40. Thoma H, Mücke W, Kauert G. Comparison of the polychlorinated dibenzo-p-dioxin and dibenzofuran in human tissue and human liver. Chemosphere 1990; 20: 433-42
41. Kreuzer PE, Csanády GA, Baur C, et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants: a toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch Toxicol 1997; 71: 383-400
42. Takenaka S, Todaka T, Nakamura M, et al. Polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and non-ortho, mono-ortho chlorine substituted biphenyls in Japanese human liver and adipose tissue. Chemosphere 2002; 49: 161-72
43. Guvenius DM, Hassanzadeh P, Bergman Å, et al. Metabolites of polychlorinated biphenyls in human liver and adipose tissue. Environ Toxicol Chem 2002; 21: 2264-9
44. Jensen S, Sundström G. Structures and levels of most chlorobiphenyls in two technical PCB products and in human adipose tissue. Ambio 1974; 3: 70-6
45. Schnellmann RG, Putnam CW, Sipes IG. Metabolism of 2,2′,3,3′,6,6′-hexachlorobiphenyl and 2,2′,4,4′,5,5′-hexachlorobiphenyl by human hepatic microsomes. Biochem Pharmacol 1983; 32: 3233-9
46. Schnellmann RG, Volp RF, Putnam CW, et al. The hydroxylation, dechlorination, and glucuronidation of 4,4′-dichlorobiphenyl (4-DCB) by human hepatic microsomes. Biochem Pharmacol 1984; 33: 3503-9
47. Sundström G, Hutzinger O, Safe S. The metabolism of chlorobiphenyls. Chemosphere 1976; 5: 267-98
48. Tai HL, McReynolds JH, Goldstein JA, et al. Cytochrome P4501A1 mediates the metabolism of 2,3,7,8- tetrachlorodibenzofuran in the rat and human. Toxicol Appl Pharmacol 1993; 123: 34-42
49. Wong TK, Everson RB, Hsu ST. Potent induction of human placental monooxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products. Lancet 1985; 325: 721-4
50. Lucier GW, Nelson KG, Everson RB, et al. Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans. Environ Health Perspect 1987; 76: 79-87
51. Lagueux J, Pereg D, Ayotte P, et al. Cytochrome P450 CYP1A1 enzyme activity and DNA adducts in placenta of women environmentally exposed to organochlorines. Environ Res 1999; 80: 369-82
52. Pereg D, Dewailly E, Poirier GG, et al. Environmental exposure to polychlorinated biphenyls and placental CYP1A1 activity in Inuit women from Northern Québec. Environ Health Perspect 2002; 110: 607-12
53. Schuur AG, van Leeuwen-Bol I, Jong WMC, et al. In vitro inhibition of thyroid hormone sulfation by polychlorobiphenylols: isozyme specificity and inhibition kinetics. Toxicol Sci 1998; 45: 188-94
54. Tampal N, Lehmler HJ, Espandiari P, et al. Glucuronidation of hydroxylated polychlorinated biphenyls (PCBs). Chem Res Toxicol 2002; 15: 1259-66
55. Bergman Å, Klasson-Wehler E, Kuroki H. Selective retention of hydroxylated PCB metabolites in blood. Environ Health Perspect 1994; 102: 464-9
56. Lans MC, Klasson-Wehler E, Willemsen M, et al. Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and - dibenzofurans with human transthyretin. Chem Biol Interact 1993; 88: 7-21
57. Kester MHA, Bulduk S, Tibboel D, et al. Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 2000; 141: 1897-900
58. Kramer VJ, Helferich WG, Bergman Å, et al. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line. Toxicol Appl Pharmacol 1997; 144: 363-76
59. Brandt I, Lund J, Bergman Å, et al. Target cells for the polychlorinated biphenyl metabolite 4,4′-bis(methylsulfonyl)-2,2′,5,5′-tetrachlorobiphenyl in lung and kidney. Drug Metab Dispos 1985; 13: 490-6
60. Chu S, Covaci A, Jacobs W, et al. Distribution of methyl sulfone metabolites of polychlorinated biphenyls and p,p′-DDE in human tissues. Environ Health Perspect 2003; 111: 1222-7
61. Haraguchi H, Kuroki H, Masuda Y, et al. Determination of methylthio and methylsulphone polychlorinated biphenyls in tissues of patients with 'Yusho'. Food Chem Toxicol 1984; 22: 283-8
62. Haraguchi K, Kuroki H, Masuda Y. Synthesis and characterization of tissue-retainable methylsulfonyl polychlorinated biphenyl isomers. J Agric Food Chem 1987; 35: 178-82
63. Lund J, Brandt I, Poellinger L, et al. Target cells for polychlorinated biphenyl metabolite 4,4′-bis (methylsulfonyl)-2,2′,5,5′-tetrachlorobiphenyl. Mol Pharmacol 1985; 27: 314-23
64. Lund J, Andersson O, Ripe E. Characterization of a binding protein for the PCB metabolite 4,4′-bis (methylsulfonyl)-2,2′,5,5′-tetrachlorobiphenyl present in bronchoalveolar lavage from healthy smokers and non-smokers. Toxicol Appl Pharmacol 1986; 83: 486-93
65. Letcher RJ, Lemmen JG, van der Burg B, et al. In vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis (4-chlorophenyl)-1,1-dichloroethene on 17β-estradiol-induced gene expression in several bioassay systems. Toxicol Sci 2002; 69: 362-72
66. Chen PH, Luo ML, Wong CK, et al. Comparative rates of elimination of some individual polychlorinated biphenyls from the blood of PCB-poisoned patients in Taiwan. Food Chem Toxicol 1982; 20: 417-25
67. Pelletier C, Imbeault P, Tremblay A. Energy balance and pollution by organochlorines and polychlorinated biphenyls. Obes Rev 2003; 4: 17-24
68. McFarland VA, Clarke JU. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 1989; 81: 225-39
69. Pang S, Cao JQ, Katz BH, et al. Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P4501A1 and 1B1. Biochem Pharmacol 1999; 58: 29-38
70. Alvares AP, Fischbein A, Anderson KE, et al. Alterations in drug metabolism in workers exposed to polychlorinated biphenyls. Clin Pharmacol Ther 1977; 22: 140-6
71. Maroni M, Colombi A, Ferioli A, et al. Evaluation of porphyrinogenesis and enzyme induction in workers exposed to PCB. Med Lav 1984; 75: 188-99
72. Emmett EA, Maroni M, Jefferys J, et al. Studies of transformer repair workers exposed to PCBs: II. results of clinical laboratory investigations. Am J Ind Med 1988; 14: 47-62
73. Apostoli P, Mangili A, Carasi S, et al. Relationship between PCBs in blood and D-glucaric acid in urine. Toxicol Lett 2003; 144: 17-26
74. Abraham K, Geusau A, Tosun Y, et al. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Clin Pharmacol Ther 2002; 72: 163-74
75. Aarts JMMJG, Denison MS, Cox MA, et al. Species-specific antagonism of Ah receptor action by 2,2′,5,5′-tetrachloro- and 2,2′,3,3′,4,4′-hexachlorobiphenyl. Eur J Pharmacol 1995; 293: 463-74
76. Biegel L, Harris M, Davis D, et al. 2,2′,4,4′,5,5′-hexachlorobiphenyl as a 2,3,7,8-terachlorodibenzo-p-dioxin antagonist in C57BL/6J mice. Toxicol Appl Pharmacol 1989; 9: 561-71
77. Haake JM, Safe S, Mayura K, et al. Aroclor 1254 as an antagonist of the teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Lett 1987; 38: 299-306
78. Harper N, Connor K, Steinberg M, et al. Immunosuppressive activity of polychlorinated biphenyl mixtures and congeners: nonadditive (antagonistic) interactions. Fundam Appl Toxicol 1995; 27: 131-9
79. Zhao F, Mayura K, Kocurek N, et al. Inhibition of 3,3′,4,4′,5-pentachlorobiphenyl-induced chicken embryotoxicity by 2,2′,4,4′,5,5′-hexachlorobiphenyl. Fundam Appl Toxicol 1997; 35: 1-8
80. Safe SH. Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach. Environ Health Perspect 1998; 106 Suppl. 4: 1051-8
81. Shelton DW, Hendricks JD, Coulombe RA, et al. Effect of dose on the inhibition of carcinogenesis/mutagenesis by aroclor 1254 in rainbow trout fed aflatoxin B 1. J Toxicol Environ Health 1984; 13: 649-57
82. Bühler F, Schmid P, Schlatter C. Kinetics of PCB elimination in man. Chemosphere 1988; 17: 1717-26
83. Schecter A, Stanley J, Boggess K, et al. Polychlorinated biphenyl levels in the tissues of exposed and nonexposed humans. Environ Health Perspect 1994; 102 Suppl. 1: 149-58
84. Hara I, Harada H, Kimura S, et al. Follow-up health examination in an electric condenser factory after cessation of PCBs usage [in Japanese]. Jpn J Ind Health 1974; 16: 365-6
85. Hara I. Health status and PCBs in blood of workers exposed to PCBs and of their children. Environ Health Perspect 1985; 59: 85-90
86. Yakushiji T, Watanabe I, Kuwabara K, et al. Long-term studies of the excretion of polychlorinated biphenyls (PCBs) through the mother's milk of an occupationally exposed worker. Arch Environ Contam Toxicol 1978; 7: 493-504
87. Steele G, Stehr-Green P, Welty E. Estimates of the biologic half-life of polychlorinated biphenyls in human serum. N Engl J Med 1986; 314: 926-7
88. Phillips DL, Smith AB, Burse VW, et al. Half-life of polychlorinated biphenyls in occupationally exposed workers. Arch Environ Health 1989; 44: 351-4
89. Brown JF, Lawton RW, Ross MR, et al. Persistence of PCB congeners in capacitor workers and Yusho patients. Chemosphere 1989; 19: 829-34
90. Wolff MS, Zeleniuch-Jacquotte A, Dubin N, et al. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 2000; 9: 271-7
91. Flesch-Janys D, Becher H, Gurn P, et al. Elimination of polychlorinated dibenzo-p-dioxins and dibenzofurans in occupationally exposed persons. J Toxicol Environ Health 1996; 47: 363-78
92. Cochran JW, Frame GM. Recent developments in the high-resolution gas chromatography of polychlorinated biphenyls. J Chromatogr A 1999; 843: 323-68
93. Barr JR, Maggio VL, Barr DB, et al. New high-resolution mass spectrometric approach for the measurement of polychlorinated biphenyls and organochlorine pesticides in human serum. J Chromatogr B 2003; 794: 137-48
94. Lawton RW, Ross MR, Feingold J, et al. Effects of PUB exposure on biochemical and hematological findings in capacitor workers. Environ Health Perspect 1985; 60: 165-84
95. Guo YL, Emmett EA, Pellizzari ED, et al. Influence of serum cholesterol and albumin on partitioning of PCB congeners between human serum and adipose tissue. Toxicol Appl Pharmacol 1987; 87: 48-56
96. Longnecker MP, Wolff MS, Gladen BC, et al. Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect 2003; 111: 65-70
97. Sweeney AM, Symanski E, Burau KD, et al. Changes in serum PBB and PCB levels over time among women of varying ages at exposure. Environ Res 2001; 86: 128-39
98. Tee PG, Sweeney AM, Symanski E, et al. A longitudinal examination of factors related to changes in serum polychlorinated biphenyl levels. Environ Health Perspect 2003; 111: 702-7
99. James RA, Hertz-Picciotto I, Willman E, et al. Determinants of serum polychlorinated biphenyls and organochlorine pesticides measured in women from the child health and development study cohort, 1963-1967. Environ Health Perspect 2002; 110: 617-24
100. Chu S, Covaci A, Schepens P. Levels and chiral signatures of persistent organochlorine pollutants in human tissues from Belgium. Environ Res 2003; 93: 167-76
101. Hovander L, Malmberg T, Athanasiadou M, et al. Identification of hydroxylated PCB metabolites and other phenolic halogenated pollutants in human blood plasma. Arch Environ Contam Toxicol 2002; 42: 105-17
102. Fängström B, Athanasiadou M, Grandjean P, et al. Hydroxylated PCB metabolites and PCBs in serum from pregnant Faroese women. Environ Health Perspect 2002; 110: 895-9
103. Schecter A. A selective historical review of congener-specific human tissue measurements as sensitive and specific biomarkers of exposure to dioxins and related compounds. Environ Health Perspect 1998; 106 Suppl. 2: 737-42
104. Tampal N, Myers S, Roberston LW. Binding of polychlorinated biphenyls/metabolites to hemoglobin. Toxicol Lett 2003; 142: 53-60
105. Brown JF, Lawton RW. Polychlorinated biphenyl (PCB) partitioning between adipose tissue and serum. Bull Environ Contam Toxicol 1984; 33: 277-80
106. Emmett EA. Polychlorinated biphenyl exposure and effects in trasformer repair workers. Environ Health Perspect 1985; 60: 185-92
107. Kimbrough RD. Human health effects of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs). Ann Rev Pharmacol Toxicol 1987; 27: 87-111
108. Sjödin A, Hagmar L, Klasson-Wehler E, et al. Influence of the consumption of fatty Baltic sea fish on plasma levels of halogenated environmental contaminants in Latvian and Swedish men. Environ Health Perspect 2000; 108: 1035-41
109. Moysich KB, Ambrosone CB, Mendola P, et al. Exposures associated with serum organochlorine levels among postmenopausal women from Western New York State. Am J Ind Med 2002; 41: 102-10
110. Glynn AW, Granath F, Aune M, et al. Organochlorines in Swedish women: determinants of serum concentrations. Environ Health Perspect 2003; 111: 349-55
111. Schwartz L. An outbreak of halowax acne ('cable rash') among electricians. JAMA 1943; 122: 158-61
112. Meigs JW, Albom JJ, Kartin BL. Chloracne from an unusual exposure to Arochlor. JAMA 1954; 154: 1417-8
113. Kashimoto T, Miyata H, Fukushima S, et al. PCBs, PCQs and PCDFs in blood of Yusho and Yu-Cheng patients. Environ Health Perspect 1985; 59: 73-8
114. Fu YA. Ocular manifestation of polychlorinated biphenyls intoxication. Am J Ind Med 1984; 5: 127-32
115. Ouw HK, Simpson GR, Siyali DS. Use and health effects of Aroclor 1242, a polychlorinated biphenyl, in an electrical industry. Arch Environ Health 1976; 31: 189-94
116. Fischbein A, Wolff MS, Lilis R, et al. Clinical findings among PCB-exposed capacitor manufacturing workers. Ann N Y Acad Sci 1979; 320: 703-15
117. Fischbein A, Rizzo JN, Solomon SJ, et al. Oculodermatological findings in workers with occupational exposure to polychlorinated biphenyls (PCBs). Br J Ind Med 1985; 42: 426-30
118. Maroni M, Colombi A, Arbosti G, et al. Occupational exposure to polychlorinated biphenyls in electrical workers: II. health effects. Br J Ind Med 1981; 38: 55-60
119. Hola N, Reznicek J. The genetic hazard involved in occupational exposure to high concentrations of polychlorinated biphenyls [in Czech]. Prac Lek 1985; 37: 386-91
120. Bosetti C, Negri E, Fattore E, et al. Occupational exposure to polychlorinated biphenyls and cancer risk. Eur J Cancer Prev 2003; 12: 251-5
121. Sinks T, Steele G, Smith AB, et al. Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol 1992; 136: 389-98
122. Sandau CD, Ayotte P, Dewailly E, et al. Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian Inuit. Environ Health Perspect 2000; 108: 611-6
123. Wilhelm M, Ewers U, Schulz C. Revised and new reference values for some persistent organic pollutants (POPs) in blood for human biomonitoring in environmental medicine. Int J Hyg Environ Health 2003; 206: 223-9
124. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 1995; 103: 346-51
125. World Health Organization. WHO consultation on risk assessment of non-dioxin-like PCBs. Available from URL: http://www.who.int/pcs/docs/consultation_%20pcb.htm [Accessed 2002 Dec 3]
126. Falck F, Ricci A, Wolff MS, et al. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 1992; 47: 143-6
127. Hunter DJ, Hankinson SE, Laden F, et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997; 337: 1253-8
128. Laden F, Collman G, Iwamoto K, et al. 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five US studies. J Natl Cancer Inst 2001; 93: 768-76
129. Laden F, Ishibe N, Hankinson SE, et al. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1560-5
130. Moysich KB, Shields PG, Freudenheim JL, et al. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8: 41-4
131. Blackwood A, Wolff M, Rundle A, et al. Organochlorine compounds (DDE and PCB) in plasma and breast cyst fluid of women with benign breast disease. Cancer Epidemiol Biomarkers Prev 1998; 7: 579-83
132. Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 525-32
133. Gladen BC, Doucet J, Hansen LG. Assessing human polychlorinated biphenyl contamination for epidemiologic studies: lessons from patterns of congener concentrations in Canadians in 1992. Environ Health Perspect 2003; 111: 437-43
134. Zheng T, Holford TR, Mayne ST, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 2000; 9: 167-74
135. Laden F, Hankinson SE, Wolff MS, et al. Plasma organochlorine levels and the risk of breast cancer: an extended follow-up in the Nurses' Health study. Int J Cancer 2001; 91: 568-74
136. Gammon MD, Wolff MS, Neugut AI, et al. Environmental toxins and breast cancer on Long Island: II. organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 2002; 11: 686-97
137. Demers A, Ayotte P, Brisson J, et al. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. Am J Epidemiol 2002; 155: 629-35
138. Holford TR, Zheng T, Mayne ST, et al. Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk. Int J Epidemiol 2000; 29: 975-82
139. Rogan WJ, Gladen BC, Hung KL, et al. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 1988; 241: 334-6
140. Lai TJ, Liu X, Guo YL, et al. A cohort study of behavioral problems and intelligence in children with high prenatal polychlorinated biphenyl exposure. Arch Gen Psychiatry 2002; 59: 1061-6
141. Gladen BC, Rogan WJ. Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl dichloroethane on later development. J Pediatr 1991; 119: 58-63
142. Jacobson JL, Jacobson SW. Sources and implications of interstudy and inter-individual variability in the developmental neurotoxicity of PCBs. Neurotoxicol Teratol 1996; 18: 257-64
143. Winneke G, Bucholski A, Heinzow B, et al. Developmental neurotoxicity of polychlorinated biphenyls (PCBS): cognitive and psychomotor functions in 7-month old children. Toxicol Lett 1998; 102-103: 423-8
144. Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MAJ, et al. Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants' mental and psychomotor development. Pediatrics 1996; 97: 700-6
145. Daniels JL, Longnecker MP, Klebanoff MA, et al. Prenatal exposure to low-level polychlorinated biphenyls in relation to mental and motor development at 8 months. Am J Epidemiol 2003; 157: 485-92
146. Schantz SL, Widholm JJ, Rice DC. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 2003; 111: 357-76
147. Schantz SL. Developmental neurotoxicity of PCBs in humans: what do we know and where do we go from here? Neurotoxicol Teratol 1996; 18: 217-27
148. Schell JD, Budinsky RA, Wernke MJ. PCBs and neurodevelopmental effects in Michigan children: an evaluation of exposure and dose characterization. Regul Toxicol Pharmacol 2001; 33: 300-12
149. Darvill T, Lonky E, Reihman J, et al. Prenatal exposure to PCBs and infant performance on the Fagan test of infant intelligence. Neurotoxicology 2000; 21: 1029-38
150. Guvenius DM, Aronsson A, Ekman-Ordeberg G, et al. Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ Health Perspect 2003; 111: 1235-41
151. Walkowiak J, Wiener JA, Fastabend A, et al. Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood. Lancet 2001; 358: 1602-7
152. Lackmann GM. Effect of polychlorinated biphenyls on psychodevelopment. Lancet 2002; 359: 1437-8
153. Ayotte P, Muckle G, Jacobson JL, et al. Assessment of pre- and postnatal exposure to polychlorinated biphenyls: lessons from the Inuit cohort study. Environ Health Perspect 2003; 111: 1253-8
154. Irvine S, Cawood E, Richardson D, et al. Evidence of deteriorating semen quality in the United Kingdom; birth cohort study in 577 men in Scotland over 11 years. BMJ 1996; 312: 467-71
155. Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 1996; 65: 1015-20
156. Hauser R, Chen Z, Pothier L, et al. The relationship between human semen parameters and environmental exposure to polychlorinated biphenyls and p,p′-DDE. Environ Health Perspect 2003; 111: 1505-11
157. Richthoff J, Rylander L, Jönsson BAG, et al. Serum levels of 2,2′,4,4′,5,5′-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ Health Perspect 2003; 111: 409-13
158. Del Rio Gomez I, Marshall T, Tsai P, et al. Number of boys born to men exposed to polychlorinated byphenyls. Lancet 2002; 360: 143-4
159. Karmaus W, Huang S, Cameron L. Parental concentration of dichlorodiphenyl dichloroethene and polychlorinated biphenyls in Michigan fish eaters and sex ratio in offspring. J Occup Environ Med 2002; 44: 8-13
160. Taylor PR, Stelma JM, Lawrence CE. The relation of polychlorinated biphenyls to birth weight and gestational age in the offspring of occupationally exposed mothers. Am J Epidemiol 1989; 129: 395-406
161. Gladen BC, Shkiryak-Nyzhnyk ZA, Chyslovska N, et al. Persistent organochlorine compounds and birth weight. Ann Epidemiol 2003; 13: 151-7
162. Gladen BC, Ragan NB, Rogan WJ. Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 2000; 136: 490-6
163. Blanck HM, Marcus M, Rubin C, et al. Growth in girls exposed in utero and postnatally to polybrominated biphenyls and polychlorinated biphenyls. Epidemiology 2002; 13: 205-10